Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Total 13F shares
-
12,754,591
-
Share change
-
+4,001,424
-
Total reported value
-
$82,807,935
-
Put/Call ratio
-
84%
-
Price per share
-
$6.87
-
Number of holders
-
77
-
Value change
-
+$25,371,624
-
Number of buys
-
55
-
Number of sells
-
13
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q3 2025
As of 30 Sep 2025 DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) had 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,754,591 shares of stock of the company.
Largest 10 holders included COOPERMAN LEON G, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, MORGAN STANLEY, FIRST MANHATTAN CO. LLC., STATE STREET CORP, and Bleichroeder LP.
This table shows 77 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.